Astrana Health
ASTH
188 hedge funds and large institutions have $759M invested in Astrana Health in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 64 increasing their positions, 57 reducing their positions, and 21 closing their positions.
1,530% more call options, than puts
Call options by funds: $16.3M | Put options by funds: $997K
129% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 21
18% more capital invested
Capital invested by funds: $642M → $759M (+$117M)
16% more funds holding
Funds holding: 162 → 188 (+26)
12% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 57
1.76% more ownership
Funds ownership: 45.94% → 47.7% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.36M |
| 2 |
3C
325 Capital
New York
|
+$8.32M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$4.93M |
| 4 |
LPL Financial
San Diego,
California
|
+$4.82M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$4.73M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4.37M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.56M |
| 4 |
Axa
Paris,
France
|
-$3.15M |
| 5 |
Millennium Management
New York
|
-$3.12M |
ASTH Hedge Fund Activity: Q3 2025 in Review
188 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q3 2025, worth a combined $759M — up 18% from $642M a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new ASTH positions and 21 closed out — a net gain of 27 holders — while 64 added to existing stakes and 57 trimmed.
The largest buyer was Ameriprise, adding an estimated $8.36M. The largest seller was Rhenman & Partners Asset Management, exiting entirely with an estimated $4.73M sold.
- 188 institutional investors held Astrana Health (ASTH) as of Q3 2025, up from 162 in Q2 2025.
- Funds reported $759M of Astrana Health stock for Q3 2025, up 18% quarter-over-quarter.
- 48 funds opened new Astrana Health positions in Q3 2025 and 21 closed out, a net change of +27 holders.
- The largest Astrana Health buyer in Q3 2025 was Ameriprise, an estimated $8.36M added.
- The largest Astrana Health seller in Q3 2025 was Rhenman & Partners Asset Management, an estimated $4.73M sold.
Based on aggregated 13F filings for Q3 2025.